PF-04427429

DRUG5 trials

Sponsors

Pfizer

Conditions

HealthyHealthy VolunteersMigraine DisordersPain

Phase 1

First In Human Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04427429 Administered Intravenously To Healthy Adult Volunteers

CompletedNCT01011296

PfizerHealthy Volunteers

Start: 2009-12-31End: 2010-05-31Target: 24Updated: 2018-12-04

Study In Healthy Adult Volunteers To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04427429

CompletedNCT01117233

Start: 2010-05-31End: 2011-11-30Updated: 2012-01-18

Acute Response Capsaicin Flare Study

CompletedNCT01147432

Start: 2010-08-31End: 2011-10-31Updated: 2011-12-21

A Clinical Study Evaluating The Safety And Tolerability Of PF-04427429 In Healthy Adult Volunteers. The Pharmacokinetics And Pharmacodynamics Of PF-04427429 Will Also Be Investigated

CompletedNCT01165723

Start: 2010-08-31End: 2012-01-31Updated: 2012-02-22

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study Of PF-04427429 In Healthy Women Volunteers

CompletedNCT01511497

PfizerMigraine Disorders, Pain

Start: 2011-10-31End: 2013-01-31Updated: 2013-02-21